Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Levorphanol, sold under the brand name Levo-Dromoran, is an opioid medication used to treat moderate to severe pain. It is the levorotatory enantiomer of the compound racemorphan. Its dextrorotatory counterpart is dextrorphan.
Community, Culture & Art
Explore the main themes, entities and connections around Levorphanol. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
name opioid receptor also drug pain racemorphan levo-dromoran enantiomer nmda similar tartrate levorotatory dextrorphan narcotic dextrorotatory antagonist opioids high brand
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Levorphanol | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Levorphanol | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Levorphanol | ATC code | None | 1.00 | infobox |
| Levorphanol | Bioavailability | 70% (oral); 100% (IV) | 1.00 | infobox |
| Levorphanol | CAS Number | 77-07-6 Y | 1.00 | infobox |
| Levorphanol | ChEMBL | ChEMBL592 N | 1.00 | infobox |
| Levorphanol | ChemSpider | 16736212 Y | 1.00 | infobox |
| Levorphanol | CompTox Dashboard (EPA) | DTXSID3023213 | 1.00 | infobox |
| Levorphanol | Drug class | Opioid | 1.00 | infobox |
| Levorphanol | DrugBank | DB00854 Y | 1.00 | infobox |
| Levorphanol | ECHA InfoCard | 100.000.912 | 1.00 | infobox |
| Levorphanol | Elimination half-life | 11–16 hours | 1.00 | infobox |
| Levorphanol | Formula | C17H23NO | 1.00 | infobox |
| Levorphanol | IUPHAR/BPS | 7595 | 1.00 | infobox |
| Levorphanol | KEGG | D08123 Y | 1.00 | infobox |
| Levorphanol | Legal status | AU: S8 (Controlled drug) | 1.00 | infobox |
| Levorphanol | Legal status | BR: Class A1 (Narcotic drugs) | 1.00 | infobox |
| Levorphanol | Legal status | CA: Schedule I | 1.00 | infobox |
| Levorphanol | Legal status | DE: Anlage II (Authorized trade only, not prescriptible) | 1.00 | infobox |
| Levorphanol | Legal status | UK: Class A | 1.00 | infobox |
| Levorphanol | Legal status | US: Schedule II | 1.00 | infobox |
| Levorphanol | MedlinePlus | a682020 | 1.00 | infobox |
| Levorphanol | Metabolism | Hepatic | 1.00 | infobox |
| Levorphanol | Molar mass | 257.377 g·mol−1 | 1.00 | infobox |
| Levorphanol | Other names | Ro 1-5431 | 1.00 | infobox |
| Levorphanol | Protein binding | 40% | 1.00 | infobox |
| Levorphanol | PubChem CID | 5359272 | 1.00 | infobox |
| Levorphanol | Routes of administration | Oral, intravenous, subcutaneous, intramuscular | 1.00 | infobox |
| Levorphanol | Trade names | Levo-Dromoran | 1.00 | infobox |
| Levorphanol | UNII | 27618J1N2X | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.